S-1/A: Hinge Health Files for IPO, Aiming to Revolutionize Musculoskeletal Care with AI

Hinge Health, a digital musculoskeletal (MSK) care company, has filed an S-1/A form with the SEC for its initial public offering (IPO), seeking to transform healthcare delivery through technology and AI.

Summary

• Hinge Health has filed for an IPO to raise capital for general corporate purposes and to fund growth strategies.
• The company aims to transform healthcare by using technology and AI to scale and automate care delivery, focusing initially on musculoskeletal (MSK) conditions.
• Hinge Health's platform provides personalized MSK care through AI-powered motion tracking, a wearable device (Enso), and a care team of physical therapists and health coaches.
• The company estimates that its platform reduces human care team hours by approximately 95% compared to traditional physical therapy.
• Hinge Health's revenue was $390.4 million in 2024, a 33% increase year-over-year, and $123.8 million for the three months ended March 31, 2025, a 50% increase year-over-year.
• The company achieved a gross margin of 77% in 2024 and 81% for the three months ended March 31, 2025.
• Hinge Health had approximately 20 million contracted lives and over 2,250 clients as of December 31, 2024.
• The company's net dollar retention rate was 117% as of December 31, 2024, and its client retention rate was 98%.
• Hinge Health is expanding into fully-insured and Medicare Advantage markets, as well as international markets.
• The company faces competition from traditional healthcare providers, digital health platforms, and health plans.

Sentiment

Score: 8

Explanation: The document presents a positive outlook for Hinge Health, with strong revenue growth, high gross margins, and a clear strategy for future expansion. The company's focus on technology and AI, as well as its commitment to improving member outcomes and reducing costs, are also positive factors.

Positives

• Strong revenue growth and high gross margins indicate a successful business model.
• High client and net dollar retention rates demonstrate customer satisfaction and recurring revenue.
• AI-powered technology and automation improve efficiency and scalability.
• Clinical studies support the effectiveness of the platform in improving member outcomes and reducing costs.
• Expansion into new markets provides opportunities for further growth.

Negatives

• The company has a history of net losses, although it achieved net income for the three months ended March 31, 2025.
• The company faces competition from various players in the healthcare market.
• The company's reliance on a limited number of health plans and partners could pose a risk if those relationships are disrupted.
• The company's increasing reliance on AI and machine learning technologies may expose it to significant risks, including development and deployment challenges, regulatory uncertainties, and potential third-party claims.

Risks

• The company may not be able to achieve or maintain profitability.
• The company may be unable to attract new clients or retain existing ones.
• A substantial portion of the company's client relationships are contracted through a limited number of health plans and other partners.
• The company's increasing reliance on AI and machine learning technologies may expose it to significant risks.
• The company may be unable to protect its intellectual property.
• The company operates in a highly regulated industry and changes in regulations could affect its operations.
• The price of the company's Class A common stock may be volatile or may decline regardless of its operating performance.
• The dual class structure of the company's common stock will concentrate voting control with the holders of Class B common stock and Series E preferred stock.

Future Outlook

Hinge Health intends to continue expanding its client base, increasing adoption across its existing client base, launching new programs, and expanding into new markets, including international expansion.

Management Comments

• We are building a new health system that transforms outcomes, experience and costs by using technology to scale and automate the delivery of care.
• We provide health care that's personalized, delivered with compassion, and treats the whole person body and mind.
• We've started by transforming musculoskeletal care so that people can get back to the things they love.

Industry Context

The announcement highlights the growing trend of using technology and AI to improve healthcare delivery and reduce costs, particularly in the musculoskeletal care market, which is a significant driver of healthcare spending.

Comparison to Industry Standards

• Hinge Health competes with digital platforms that provide broad care or programs that address a segment of MSK care, such as Kaia Health Software, Inc., Omada Health, Inc., Sword Health Technologies, Inc., and Vori Health, Inc.
• The document highlights Hinge Health's competitive strengths, including its scale and market leadership, member-first digital care delivery, AI technology and data advantage, scalable go-to-market strategy, outcomes for members and ROI to clients, and platform extensibility and innovation.
• The document cites a 2023 Employer Claims Study that estimated a 2.4x ROI for Hinge Health clients, based on the estimated $2,387 average cost savings per member over a 12-month period divided by the cost of the chronic program.
• The document cites a 2020 Longitudinal Study that evaluated the efficacy of Hinge Health's platform in a large population of participants with chronic knee and back pain, where participants reported a 68% average improvement in reported pain and a 58% reduction in reported depression and anxiety after 12 weeks.

Related Party Transactions

• In February 2025, the company entered into a stock repurchase agreement with Coatue, a holder of more than 5% of the company's outstanding capital stock, to repurchase shares of Series E preferred stock for $50.0 million.
• In February 2025, the company entered into a participation letter with Coatue, granting Coatue the right to purchase up to 5% of the shares of Class A common stock offered in the IPO.
• From time to time, the company engages the law firm of Perkins Coie LLP for various legal services. A sibling of Daniel Perez, the company's Chief Executive Officer and Director, is a partner with Perkins Coie LLP.

Stakeholder Impact

• Shareholders: The IPO will provide liquidity for existing shareholders and allow them to realize the value of their investment.
• Employees: The IPO will provide employees with the opportunity to participate in the company's success through stock ownership.
• Customers: The company's continued growth and innovation will allow it to provide better and more effective MSK care to its members.
• Suppliers: The company's growth will create more opportunities for its suppliers.
• Creditors: The company's improved financial position will make it a more attractive borrower.

Next Steps

• The company intends to use the net proceeds from the IPO to satisfy tax withholding and remittance obligations related to the RSU Net Settlement.
• The company intends to use any remaining net proceeds primarily for general corporate purposes, working capital, and to fund its growth strategies and initiatives.
• The company may also use a portion of the net proceeds to acquire or invest in complementary businesses, products, services, technologies, or other assets.

Key Dates

Keywords

musculoskeletal care, digital health, artificial intelligence, telehealth, healthcare, IPO, Hinge Health, MSK, AI, Enso